Interleukin-26 activates macrophages and facilitates killing of Mycobacterium tuberculosis
Heike C. Hawerkamp, Lasse van Geelen, Jan Korte, Jérémy Di Domizio, Marc Swidergall, Afaque A. Momin, Francisco J. Guzmán‐Vega, Stefan T. Arold, et al. (13 authors)
Scientific Reports · 2020-10
Abstract
Abstract Tuberculosis-causing Mycobacterium tuberculosis (Mtb) is transmitted via airborne droplets followed by a primary infection of macrophages and dendritic cells. During the activation of host defence mechanisms also neutrophils and T helper 1 (T H 1) and T H 17 cells are recruited to the site of infection. The T H 17 cell-derived interleukin (IL)-17 in turn induces the cathelicidin LL37 which shows direct antimycobacterial effects. Here, we investigated the role of IL-26, a T H 1- and T H 17-associated cytokine that exhibits antimicrobial activity. We found that both IL-26 mRNA and protein are strongly increased in tuberculous lymph nodes. Furthermore, IL-26 is able to directly kill Mtb and decrease the infection rate in macrophages. Binding of IL-26 to lipoarabinomannan might be one important mechanism in extracellular killing of Mtb. Macrophages and dendritic cells respond to IL-26 with secretion of tumor necrosis factor (TNF)-α and chemokines such as CCL20, CXCL2 and CXCL8. In dendritic cells but not in macrophages cytokine induction by IL-26 is partly mediated via Toll like receptor (TLR) 2. Taken together, IL-26 strengthens the defense against Mtb in two ways: firstly, directly due to its antimycobacterial properties and secondly indirectly by activating innate immune mechanisms.
MeSH terms
- Mycobacterium tuberculosis
- Innate immune system
- Antimycobacterial
- Microbiology
- TLR2
- CCL20
- Lipoarabinomannan
- Chemokine
- Immunology
- Cytokine
- Tumor necrosis factor alpha
- Immune system
- Biology
- Chemistry
- Tuberculosis